Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
NCT: NCT03465774 · RECRUITING
Brief Summary
This study is designed to obtain preliminary data comparing indwelling pleural catheters (IPCs) versus IPCs plus doxycycline for pleurodesis as treatments for malignant pleural effusion (MPE). Indwelling pleural catheters (IPCs) are commonly used to treat pleural effusions (build-up of fluid in the lungs). Doxycycline is an antibiotic that is also used to treat pleural effusions. The goal of this clinical research study is to learn if adding doxycycline to the use of an IPC can lead to shorter treatment times with IPCs.
Frequently Asked Questions
What is Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions?
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions is a clinical trial registered under NCT03465774. Current status: RECRUITING.
What is the status of NCT03465774?
The current status of NCT03465774 (Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions) is: RECRUITING.
When did Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions start?
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions started on 2018-03-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.